Hepatoblastoma medical therapy: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 8: Line 8:
*[[Chemotherapy]] has been proven effective in both an [[adjuvant]] and [[neoadjuvant]] treatment and can shrink tumors.
*[[Chemotherapy]] has been proven effective in both an [[adjuvant]] and [[neoadjuvant]] treatment and can shrink tumors.
*It makes them less prone to bleed and delineates the tumor from the surrounding normal parenchyma and vascular structures so as to facilitate the resections.
*It makes them less prone to bleed and delineates the tumor from the surrounding normal parenchyma and vascular structures so as to facilitate the resections.
*Hepatoblastoma is sensitive to such chemotherapy drugs as [[doxorubicin]], [[cisplatin]], [[vincristine]], [[5-Fluorouracil]] and [[cyclophosphamide]].
*Hepatoblastoma is sensitive to such chemotherapy drugs as [[doxorubicin]], [[cisplatin]], [[vincristine]], [[5-Fluorouracil]], and [[cyclophosphamide]].
==References==
==References==
{{reflist|1}}
{{reflist|1}}

Revision as of 22:16, 13 November 2015

Hepatoblastoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Epidemiology and Demographics

Risk Factors

Screening

Differentiating Hepatoblastoma from other Diseases

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hepatoblastoma medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hepatoblastoma medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hepatoblastoma medical therapy

CDC on Hepatoblastoma medical therapy

Hepatoblastoma medical therapy in the news

Blogs on Hepatoblastoma medical therapy

Directions to Hospitals Treating Hepatoblastoma

Risk calculators and risk factors for Hepatoblastoma medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Nawal Muazam M.D.[2]

Overview

The predominant therapy for hepatoblastoma is surgical resection. Neoadjuvant and adjuvant chemotherapy may be required.[1]

Medical Therapy

Adjuvant chemotherapy prior to resection have been used to treat hepatoblastoma.[1]

References

  1. 1.0 1.1 Madabhavi, Irappa; Patel, Apurva; Choudhary, Mukesh; Aagre, Suhas; Revannasiddaiah, Swaroop; Modi, Gaurang; Anand, Asha; Panchal, Harsha; Parikh, Sonia; Raut, Shreeniwas (2014). "Paraneoplastic Recurrent Hypoglycaemic Seizures: An Initial Presentation of Hepatoblastoma in an Adolescent Male—A Rare Entity". Case Reports in Pediatrics. 2014: 1–5. doi:10.1155/2014/104543. ISSN 2090-6803.


Template:WikiDoc Sources